Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LXI-15028 in Non-erosive Reflux Disease
NCT03591653Phase 3Completed
- Sponsor
- Shandong Luoxin Pharmaceutical
- Start
- Oct 2018
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tegoprazan in non-erosive reflux disease (NERD), sponsored by Shandong Luoxin Pharmaceutical. Started Oct 2018; status: completed.
02
Drugs
tegoprazan
03
Conditions
non-erosive reflux disease (NERD)
Beyond the preview
Go deeper on NCT03591653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03591653.